StockData
OrthoPediatrics Corp logo

OrthoPediatrics Corp (KIDS) stock

KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/305% below fair value
$31.74−0.77 (-2.37%)

Close on Nov 20, 2026Market cap $828.75MP/E –Yield –

OrthoPediatrics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

OrthoPediatrics's operating income for the twelve months ending Sep 30, 2026 was -$24.80M. For fiscal 2025 it was -$39.24M. The highest annual figure on record is -$6.13M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$39.24M–
FY2024Dec 31, 2024-$35.01M–
FY2023Dec 31, 2023-$26.75M–
FY2022Dec 31, 2022-$25.40M–
FY2021Dec 31, 2021-$18.02M–
FY2020Dec 31, 2020-$26.76M–
FY2019Dec 31, 2019-$9.08M–
FY2018Dec 31, 2018-$9.55M–
FY2017Dec 31, 2017-$6.47M–
FY2016Dec 31, 2016-$6.13M–
FY2015Dec 31, 2015-$6.59M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$4.23M–
Q2 FY2026Jun 30, 2026-$4.07M–
Q1 FY2026Mar 31, 2026-$8.34M–
Q4 FY2025Dec 31, 2025-$8.17M–
Q3 FY2025Sep 30, 2025-$9.43M–
Q2 FY2025Jun 30, 2025-$10.66M–
Q1 FY2025Mar 31, 2025-$10.98M–
Q4 FY2024Dec 31, 2024-$14.06M–
Q3 FY2024Sep 30, 2024-$5.57M–
Q2 FY2024Jun 30, 2024-$5.67M–
Q1 FY2024Mar 31, 2024-$9.72M–
Q4 FY2023Dec 31, 2023-$8.07M–
Q3 FY2023Sep 30, 2023-$4.51M–
Q2 FY2023Jun 30, 2023-$5.59M–
Q1 FY2023Mar 31, 2023-$8.59M–
Q4 FY2022Dec 31, 2022-$8.31M–
Q3 FY2022Sep 30, 2022-$6.96M–
Q2 FY2022Jun 30, 2022-$3.74M–
Q1 FY2022Mar 31, 2022-$6.39M–
Q4 FY2021Dec 31, 2021-$5.56M–
Q3 FY2021Sep 30, 2021-$3.64M–
Q2 FY2021Jun 30, 2021-$2.85M–
Q1 FY2021Mar 31, 2021-$5.97M–
Q4 FY2020Dec 31, 2020-$12.74M–
Q3 FY2020Sep 30, 2020-$2.50M–
Q2 FY2020Jun 30, 2020-$7.02M–
Q1 FY2020Mar 31, 2020-$4.50M–
Q4 FY2019Dec 31, 2019-$3.03M–
Q3 FY2019Sep 30, 2019-$1.54M–
Q2 FY2019Jun 30, 2019-$1.79M–
Q1 FY2019Mar 31, 2019-$2.72M–
Q4 FY2018Dec 31, 2018-$1.87M–
Q3 FY2018Sep 30, 2018-$1.17M–
Q2 FY2018Jun 30, 2018-$2.12M–
Q1 FY2018Mar 31, 2018-$4.40M–
Q4 FY2017Dec 31, 2017-$4.20M–
Q3 FY2017Sep 30, 2017-$754.00K–
Q2 FY2017Jun 30, 2017-$677.00K–
Q1 FY2017Mar 31, 2017-$837.00K–
Q4 FY2016Dec 31, 2016-$3.25M–

More OrthoPediatrics figures

See a number that looks wrong?